EU clears Pathway Medical's peripheral atherectomy catheter

12/15/2009 | Clinica (subscription required)

EU regulators have granted CE Mark approval to Pathway Medical Technologies' Jetstream G2 NXT, a catheter used for treating patients with peripheral arterial disease. The device, which secured 510(k) clearance from the FDA in August, features an expandable tip that allows doctors to extract plaque and other lesions from the patient's lower limbs.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ